Mohr Davidow Ventures

News, insights, analysis and data

← Back to Mohr Davidow Ventures profile

Mohr Davidow Ventures related stories

All articles and analysis

  • BuildDirect closes $30 mln Series B funding
    Chris Witkowsky- 21 January 2014

    BuildDirect, which provides an online shopping platform for building professionals to amateurs, has received $30 million in Series B funding. The funding round was led by Mohr Davidow Ventures and supported by high profile Canadian investors including existing investor BDC Venture Capital. Katherine Barr, general partner at Mohr Davidow, will join the company's board of directors.

  • People Pattern raises Series A led by Mohr Davidow Ventures
    Angela Sormani- 2 January 2014

    People Pattern has raised a $4.5 Million Series A funding. Mohr Davidow Ventures, who was a seed investor in People Pattern earlier in 2013, led the investment round with additional participation from private investors. People Pattern has built an advanced analytics marketing platform for audience segmentation, user classification, and audience activation.

  • The incredible shrinking venture industry
    Mark Boslet- 1 January 2014

    Many VCs believe the business has finally right-sized, but don’t place your bets too quickly

  • People Pattern raises $4.5 mln in Series A funding
    Chris Witkowsky- 31 December 2013

    People Pattern, which provides an advanced analytics marketing platform, has raised $4.5 million in a Series A funding round led by Mohr Davidow Ventures, which was a seed investor in the company earlier in 2013. Private investors also participated in the funding round. Bryan Stolle, general partner at Mohr Davidow, will join People Pattern's board of directors.

  • Social scene: Venture Alpha West 2013
    Staff Writer- 2 December 2013

    It was a memorable two-and-a-half days at the Venture Alpha West conference in early October in Half Moon Bay, Calif.

  • VC-backed CardioDX shelves IPO - Silicon Valley Business Journal
    Iris Dorbian- 15 November 2013

    According to the Silicon Valley Business Journal http://www.bizjournals.com/sanjose/news/2013/11/15/cardiodx-pulls-ipo-citing-poor-market.html CardioDX has postponed its IPO. The publication reported that the company cited unfavorable market conditions as the reason for the deferral. CardioDX was scheduled to start trading its stock on the NASDAQ under the ticker symbol “CDX" on November 14, 2013. Headquartered in Palo Alto, Calif., CardioDx is a molecular diagnostics company specializing in cardiovascular genomics. Investors include V-Sciences Investments, Longitude Venture Partners, Artiman Ventures, Kleiner Perkins Caufield & Byers, JP Morgan and Mohr Davidow Ventures.

  • Mohr Davidow backs content aggregator OneSpot
    Alastair Goldfisher- 14 November 2013

    OneSpot, an Austin, Texas-based company provider that aggregates advertising content for online publishers, has raised a $5.3 million Series A round led by Mohr Davidow Ventures. Mack Capital, RSL Ventures, Capital Factory and Bazaarvoice co-founder Brett Hurt also participated in the round. OneSpot said it has now raised $6.8 million in total funding. As part of the funding, Bryan Stolle, general partner of Mohr Davidow, has joined the board.

  • DAG Ventures leads $4.5 mln round for Mustbin
    Iris Dorbian- 13 November 2013

    Mustbin has raised $4.5 million in Series A funding. DAG Ventures led the round with participation from General Catalyst Partners, Mohr Davidow Ventures, Northgate Capital, Hubspot co-founder Dharmesh Shah, Jonathan Kraft and angel investors. Mustbin is an app for organizing, storing and sharing vital personal information.

  • VC-backed CardioDX prices IPO - Silicon Valley Business Journal
    Iris Dorbian- 5 November 2013

    According to the Silicon Valley Business Journal http://www.bizjournals.com/sanjose/news/2013/11/05/cardiodx-sets-ipo-price-targets-for.html CardioDX has set pricing terms for its IPO. The publication reports that the company plans on selling 5 million shares at a price between $14 and $16 a share.  CardioDX will trade its stock on the NASDAQ under the ticker symbol "CDX." BofA Merrill Lynch and Jefferies LLC will serve as lead underwriters. Headquartered in Palo Alto, Calif., CardioDx is a molecular diagnostics company specializing in cardiovascular genomics. Investors include V-Sciences Investments, Longitude Venture Partners, Artiman Ventures, Kleiner Perkins Caufield & Byers, JP Morgan and Mohr Davidow Ventures.

  • KP reorganizes its early-stage team and other VC fund briefs
    Staff Writer- 1 November 2013

    Five partners at Kleiner Perkins to focus on early-stage deals; 500 Startups closes above $44 mln; and Q3 fundraising numbers drop